| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |